← back to search

Terry Jo Bichell

Brentwood Hospital ·
Area of research
Genetics · Cellular and Molecular Neuroscience
Research interest
Research interests include Genetic Syndromes and Imprinting, Genetic Neurodegenerative Diseases, Genomics and Rare Diseases, and Genetics and Neurodevelopmental Disorders.
h-index
16
citations
1,051
works
45
NIH funding
primary concept
email

Recent publications

Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)
Journal of Neurodevelopmental Disorders 2023cited by 26position: middledoi
Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model
Child Psychiatry & Human Development 2020cited by 78position: lastdoi
Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017cited by 44position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Meghan T. Miller · Ludwig-Maximilians-Universität München2 papers (2020–2023)Michelle L. Krishnan · Roche (Switzerland)2 papers (2020–2023)Lynne M. Bird · University of California San Diego2 papers (2020–2023)Robert W. Komorowski · Ionis Pharmaceuticals (United States)1 papers (2023–2023)Wen‐Hann Tan · Princeton University1 papers (2023–2023)Dawn Phillips · University of Florida1 papers (2020–2020)Kyle J. Horning · University of Arizona1 papers (2017–2017) · 1 papers (2020–2020) · 1 papers (2017–2017) · 1 papers (2017–2017) · 1 papers (2017–2017)Alexander P. Osmand · University of Tennessee at Knoxville1 papers (2017–2017) · 1 papers (2017–2017)Shafali Jeste · University of California, Los Angeles1 papers (2023–2023)Anne Wheeler · Hospital for Sick Children1 papers (2023–2023)Rebecca Crean · Ionis Pharmaceuticals (United States)1 papers (2023–2023) · 1 papers (2020–2020) · 1 papers (2023–2023) · 1 papers (2017–2017) · 1 papers (2020–2020)